Gary Doolittle
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Vaccine Enriched, Autologous, Activated T-Cells Directed to Tumor in Patients With Relapsed/Refractory Melanoma (NCT02482532) | Gary Doolittle | 2016-10-06 |
Track Gary Doolittle automatically
Every clearance here is in the API, with alerts when new ones post.